Resveratrol Attenuates the Release of Inflammatory Cytokines from Human Bronchial Smooth Muscle Cells Exposed to Lipoteichoic Acid in Chronic Obstructive Pulmonary Disease

Inflammatory Responses of Airway Smooth Muscle Cells and Effects of Endothelin Receptor Antagonism

(2013) Jürgen Knobloch et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

(2013) Jörg D. Leuppi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of lipoteichoic acid on IL-2 and IL-5 release from T lymphocytes in asthma and COPD

(2012) Zeynep Mat et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Resveratrol: French Paradox Revisited

(2012) Betul Catalgol et al.   Frontiers in Pharmacology

Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease

(2012) Kazuhiro Ito et al.   International Journal of Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease Th1 Cells Display Impaired Response to Endotoxin

(2011) José A. Bengoechea et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Acute Exacerbations of Chronic Obstructive Pulmonary Disease

(2011) Mona Bafadhel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Resveratrol Impairs the Release of Steroid-resistant Cytokines from Bacterial Endotoxin-Exposed Alveolar Macrophages in Chronic Obstructive Pulmonary Disease

(2011) Jürgen Knobloch et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Airway smooth muscle and immunomodulation in acute exacerbations of airway disease

(2011) Cynthia J. Koziol-White et al.   IMMUNOLOGICAL REVIEWS

Activation of Sirt1 by Resveratrol Inhibits TNF-α Induced Inflammation in Fibroblasts

(2011) Xiaoxia Zhu et al.   PLoS One

Bacteriological Differences Between COPD Exacerbation and Community-Acquired Pneumonia

(2011) X.-J. Li et al.   Respiratory Care

The T-Helper Cell Type 1 Immune Response to Gram-Negative Bacterial Infections Is Impaired in COPD

(2010) Jürgen Knobloch et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Resveratrol Impairs the Release of Steroid-Resistant Inflammatory Cytokines from Human Airway Smooth Muscle Cells in Chronic Obstructive Pulmonary Disease

(2010) J. Knobloch et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results

(2009) C. Crim et al.   EUROPEAN RESPIRATORY JOURNAL

Glucocorticoid resistance in inflammatory diseases

(2009) Peter J Barnes et al.   LANCET

Resveratrol bioavailability and toxicity in humans

(2009) Charles-Henry Cottart et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Transcriptional regulation of cytokine function in airway smooth muscle cells

(2009) Deborah Clarke et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

TNF -induced GM-CSF release from human airway smooth muscle cells depends on activation of an ET-1 autoregulatory positive feedback mechanism

(2009) J Knobloch et al.   THORAX

From Natural Products to Small Molecule Ketone Histone Deacetylase Inhibitors: Development of New Class Specific Agents

(2008) Philip Jones et al.   CURRENT PHARMACEUTICAL DESIGN

TLR2 – promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity

(2008) Ulrich Zähringer et al.   IMMUNOBIOLOGY

The cytokine network in asthma and chronic obstructive pulmonary disease

(2008) Peter J. Barnes   JOURNAL OF CLINICAL INVESTIGATION

Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 Inhibitors

(2008) Tero Huhtiniemi et al.   JOURNAL OF MEDICINAL CHEMISTRY

Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases

(2008) Mitchell D Knutson et al.   NUTRITION REVIEWS

Review: Antioxidant therapeutic advances in COPD

(2008) Irfan Rahman   Therapeutic Advances in Respiratory Disease